The Consortium of Rheumatology Researchers of North America (Corrona), one of the largest real-world prospective data sets for rheumatoid arthritis (RA), has expanded to include datasets for other autoimmune diseases, including gout, inflammatory bowel disease, psoriatic arthritis/spondyloarthropathy, psoriasis, and multiple sclerosis.
Leslie R. Harrold, chief scientific officer at Corrona LLC, explained that the “goal is to gain a deeper understanding of patterns of care, effectiveness and safety outcomes in autoimmune diseases.”
Since 2011, over 430 abstracts at medical conferences and 144 manuscripts were created using data collected through Corrona. Read the full article to understand how this data is used in assessing treatment effectiveness and safety of medications: https://www.healio.com/rheumatology/rheumatoid-arthritis/news/online/%7B426b1f70-8ddd-4e9b-9f4c-5249fa43f437%7D/corrona-leveraging-big-data-for-improved-patient-outcomes
DADOS allows clinicians to monitor their patients’ progress and adjust their treatment plans as necessary, and can also prospectively collect data to power research initiatives.